AddedRisk Factors
Due to scheduled step downs of the required consolidated leverage ratio under our U.S. revolving credit facility (the "U.S. Revolving Credit Facility") taking effect beginning in the first quarter of 2026, we believe we may be unable to comply with the consolidated leverage ratio in its current form within the twelve-month period subsequent to the date of this filing unless we are able to implement sufficient mitigation strategies. Such strategies include, but are not limited to, amending the outstanding U.S. Revolving Credit Facility consistent with prior similar amendments we have obtained over the past several years, obtaining a waiver of the default, replacing the U.S. Revolving Credit Facility with a new revolving credit facility, consummating additional divestiture opportunities, and/or reducing operating costs. Implementation of such strategies may increase our borrowing costs under existing material financing arrangements. If we are not able to implement sufficient mitigating strategies and are therefore not able to comply with the consolidated leverage ratio, the lenders under the U.S. Revolving Credit Facility could elect to terminate the facility. As of the date of this filing, the U.S. Revolving Credit Facility has no outstanding borrowings.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RemovedRisk Factors
impact of incidents, particularly for sophisticated attacks. These factors may inhibit our ability to provide prompt, full, and reliable information about the incident to our customers, partners, regulators, and the public.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedRisk Factors
formaldehyde under the TSCA. We anticipate that, consistent with the TSCA, the EPA will develop a draft risk management plan that is expected to be released for public comment in approximately 12 months.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RewordedRisk Factors
Shell Chemicals Europe, another group certain Repsol entities represented by Stichting Ethylene Claims ("Stichting"), TotalEnergies, OMV, Borealis, LyondellBasell, and more recently, Stichting, on behalf of corporate claimants, and, most recently, TotalEnergies Petrochemicals & Refining SA Versalis entities, have each filed separate claims for damages with the District Court of Amsterdam against four companies, including the Company, Celanese, arising from those activities.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
If the potential financial and other benefits and synergies of the M&M Business going forward do not materialize in the amounts or on the timing we expect, or if we are not as successful as we plan at aligning our and the M&M Business's practices and operations, then our business, financial performance and operating results could be adversely affected.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
The intended closure of our facility in Mechelen, Belgium, resulted in charges during fiscal 2024 and Lanaken, Belgium is expected to result in charges charges, including employee termination costs, of $140 million through fiscal 2028. 2027.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Despite our level of indebtedness, we expect to continue to have the ability to borrow additional debt. debt though there is no guarantee we will be able to borrow on the same terms as our existing indebtedness.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
In During the fourth quarter of three months ended December 31, 2022, we concluded settlement discussions with the Dutch tax authority, and in during the third quarter of three months ended September 30, 2024, we concluded settlement discussions with the German tax authority related to the German transfer pricing audit.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
The Credit Agreements require the maintenance of certain financial ratios and contain other covenants including, but not limited to, restrictions on our and certain of our subsidiaries' ability to incur additional debt; incur liens securing debt; increase dividends, repurchase our Common Stock or make other restricted payments; merge or consolidate with any other person; and sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of the Issuer's assets or the assets of certain subsidiaries.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our operations are also subject to global political conditions, which may be subject to heightened uncertainty as a result of changes in governmental administration in the jurisdictions in which we operate and elsewhere. uncertainty.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
In furtherance of our deleveraging efforts, we have completed our planned divestiture of the Micromax® business, executed a number of transactions to manage our debt maturity profile, paused our share repurchase program and are in the process of evaluating additional cash generation or conservation opportunities.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
We may incur significant charges or experience other significant risks and uncertainties in the event we close or divest all or part of a manufacturing plant or facility and or engage in other divestitures that introduce significant risks and uncertainties. divestitures.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Physical impacts that could be associated with climate change, such as increased frequency and severity of hurricanes and fires, droughts, hurricanes, floods and impact other weather events and impacts on sea levels, as well as other catastrophic events, may also impact our facilities and operations and those of our key suppliers.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Failure to develop new products products, product applications, and production technologies, or to implement productivity and cost reduction initiatives successfully, technologies may harm our competitive position.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our indebtedness and interest expense, could adversely affect us, decrease our business flexibility, diminish our ability to raise additional capital to fund our operations or refinance our existing indebtedness when it matures, adversely affect our credit ratings, ratings (which may in turn increase our interest expense), and limit our ability to react to changes in the economy or the chemicals industry.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
The Indentures contain covenants including, but not limited to, restrictions on our and certain of our subsidiaries' ability to incur liens securing debt; merge or consolidate with any other person; and sell, assign, transfer, lease, leaseback, convey or otherwise dispose of certain or all or substantially all of the Issuer's assets or the assets of certain subsidiaries.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
•lower spending of $195 million, primarily as a result of the realization of synergy and cost savings actions in our Engineered Materials and Other Activities segments during the year ended December 31, 2025; and
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
•current year impacts of a non-deductible goodwill impairment loss, recognition of a valuation allowance on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period, the further integrated global principal operations and the relocation of certain intangible assets among wholly-owned foreign affiliates and the settlement of tax examinations with German tax authorities; and
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
•lower spending of $98 million, primarily as a result of the realization of synergy and cost savings actions during the year ended December 31, 2025; and
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
•a decrease in earnings from our Ibn Sina strategic affiliate, primarily due to lower methyl tertiary-butyl ether ("MTBE") volume arising from weaker economic conditions, as well as lower MTBE pricing and higher feedstock costs.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
•lower volume across the chain, primarily for acetate tow, due to decreased global demand;
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
•lower spending of $97 million, primarily due to realization of synergy and cost savings actions during the year ended December 31, 2025.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
•an increase in proceeds from long-term debt, primarily due to $4.0 billion in proceeds received from the March 2025 Offering (defined below) and December 2025 Offering (defined below);
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Celanese (Nanjing) Chemical Co., Ltd. ("CNCC") has entered into various working capital loans that bear interest at floating interest rates or fixed interest rates and expire on various dates beginning December 2026 through July 2028. These working capital loans have an outstanding balance of $571 million as of December 31, 2025.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
On April 11, 2025, CNCC entered into a CNY100 million revolving credit facility guaranteed by Celanese U.S. (the "CNCC Revolving Credit Facility" and together with the CSIT Revolving Credit Facility, the "China Revolving Credit Facilities") expiring 12 months from the drawdown date. No draws were initiated as of December 31, 2025.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
On October 20, 2025, CNCC entered into a CNY300 million working capital loan expiring three years from the drawdown date. No draws were initiated as of December 31, 2025.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
We are in compliance with the covenants in our material financing arrangements as of December 31, 2025.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Due to scheduled step downs of the required consolidated leverage ratio under the U.S. Revolving Credit Facility taking effect beginning in the first quarter of 2026, we believe we may be unable to comply with the consolidated leverage ratio in its current form within the twelve-month period subsequent to the date of this filing unless we are able to implement sufficient mitigation strategies. Such strategies include, but are not limited to, amending the outstanding U.S. Revolving Credit Facility consistent with prior similar amendments we have obtained over the past several years, obtaining a waiver of the default, replacing the U.S. Revolving Credit Facility with a new revolving credit facility, consummating additional divestiture opportunities, and/or reducing operating costs. Implementation of such strategies may increase our borrowing costs under existing material financing arrangements. If we are not able to implement sufficient mitigating strategies and are therefore not able to comply with the consolidated leverage ratio, the lenders under the U.S. Revolving Credit Facility could elect to terminate the facility. As of the date of this filing, the U.S. Revolving Credit Facility has no outstanding borrowings. We currently do not expect to draw on the U.S. Revolving Credit Facility to fund our operations or financial obligations within the twelve-month period subsequent to the date of this filing and expect to have sufficient liquidity available to meet our operational and capital investment needs and financial obligations for the foreseeable future.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RemovedMD&A
•risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility;
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
•higher volume in our Acetyl Chain segment for most of our products, primarily methanol, downstream derivative products, acid, and VAM.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
•prior year impacts that did not recur in the current year, including the relocation of certain intangible assets to better align with the acquired M&M foreign operations, the realignment of our European headquarters and principal operations to Switzerland to achieve operational efficiencies, the release of valuation allowances on U.S. foreign tax credit carryforwards, and the excess of the U.S. GAAP gain over the tax gain from the formation of the Nutrinova joint venture; and
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
•lower volume, primarily driven by the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information) and reduced demand for elastomers due to weaker automotive demand, partially offset by higher volume for certain products, principally for POM in Europe and Asia;
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
•higher volume for most of our products, primarily methanol, downstream derivative products, acid, and VAM.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
•higher spending of $40 million, primarily as a result of increased plant operating and maintenance expenses, including costs at our new acetic acid unit at Clear Lake, Texas, and plant turnaround costs related to our joint venture, Fairway Methanol LLC;
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
•lower raw material and sourcing costs, primarily for carbon monoxide and methanol.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
In September 2023, we formed a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova. We contributed receivables, inventory, property, plant and equipment, certain other assets, liabilities, technology and employees of our food ingredients business while retaining a 30% interest in the joint venture. Mitsui acquired the remaining 70% interest in the food ingredients business for a purchase price of $503 million, subject to transaction adjustments. We accounted for our interest in the joint venture as an equity method investment, and our portion of the results will continue to be included in the Engineered Materials segment. For further information regarding the food ingredients joint venture, see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
We remain in compliance with the covenants in the existing Global Credit Agreements (defined below, and as amended to date) and expect to remain in compliance based on our current expectation of future results of operations and planned cash generation activities. If the actual future results of our operations and cash generation activities differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the existing Global Credit Agreements.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
•a decrease in proceeds of long-term debt, primarily due to the issuance of certain senior unsecured notes of $3.0 billion during the year ended December 31, 2023, that did not recur in the current year, partially offset by current year borrowings on working capital loan facilities in China; and
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
Also in January 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn in January 2023 and was fully repaid during the three months ended March 31, 2024.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RemovedMD&A
In December 2023, Celanese (Nanjing) Chemical Co., Ltd. ("CNC") entered into a senior unsecured working capital loan agreement for CNY800 million, payable on December 25, 2026 and bearing interest at 2.8% (the "CNC Working Capital Loan Agreement"). The loan under the CNC Working Capital Loan Agreement was fully drawn during the three months ended March 31, 2024.
Read it in 10-K Feb 21, 2025 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2025 2024 2023 Change (In $ millions, except percentages) Statement of Operations Data Net sales 10,280 10,940 (660) 9,544 10,268 (724) Gross profit 2,356 2,603 (247) 1,952 2,336 (384) Selling, general and administrative ("SG&A") expenses (1,030) (1,075) 45 (899) (1,033) 134 Other (charges) gains, net (1,581) (1,744) (68) (1,676) 163 Gain (loss) on disposition of businesses and assets, net (5) (14) 505 (519) 9 Operating profit (loss) (697) 1,687 (2,384) (786) (720) (66) Equity in net earnings (loss) of affiliates 127 196 102 94 (69) Non-operating pension and other postretirement employee benefit (expense) income 55 (20) (69) 49 75 Interest expense (701) (676) (720) 44 (25) Refinancing expense (68) — (68) Interest income 24 33 39 (6) (9) Dividend income - equity investments 122 128 126 2 (6) Earnings (loss) from continuing operations before tax (996) 1,183 (2,179) (1,220) (1,019) (201) Earnings (loss) from continuing operations (1,506) 1,973 (3,479) (1,130) (1,526) 396 Earnings (loss) from discontinued operations (21) (8) (9) 1 (13) Net earnings (loss) (1,514) 1,964 (3,478) (1,151) (1,534) 383 Net earnings (loss) attributable to Celanese Corporation (1,522) 1,960 (3,482) (1,165) (1,542) 377 Other Data Depreciation and amortization 760 801 706 95 (41) SG&A expenses as a percentage of Net sales 10.0 9.4 % 9.8 10.1 % Operating margin(1) (6.8) (8.2) % 15.4 (7.0) % Other (charges) gains, net Restructuring (68) (107) (52) (55) 39 Asset impairments impairment losses (1,513) (1,639) (15) (1,624) 126 Plant/office closures — 2 (1) 3 (2) Total Other (charges) gains, net (1,581) (1,744) (68) (1,676) 163
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended % December 31, 2025 2024 2023 Change Change (In $ millions, except percentages) Net sales 4,763 4,884 (121) (2.5)% 5,390 5,595 (205) (3.7)% Net Sales Variance Volume 4 (4) % Price (6) (1) % Currency — 1 % Other (charges) gains, net (1,552) (1,724) 172 10.0% Operating profit (loss) 951 1,109 (158) (14.2)% (958) (1,197) 239 20.0% Operating margin 20.0 (17.8) % 22.7 (21.4) % Dividend income - equity investments 127 124 3 2.4% Equity in net earnings (loss) of affiliates 105 172 (67) (39.0)% Depreciation and amortization 244 217 27 12.4% 447 510 (63) (12.4)%
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended % December 31, 2025 2024 2023 Change Change (In $ millions, except percentages) Net sales 4,232 4,763 4,884 (121) (2.5)% (531) (11.1)% Net Sales Variance Volume 4 (6) % Price (6) % Currency — 1 % Operating profit (loss) 951 1,109 (158) (14.2)% 539 946 (407) (43.0)% Operating margin 20.0 12.7 % 22.7 19.9 % Dividend income - equity investments 121 127 124 3 2.4% (6) (4.7)% Depreciation and amortization 263 244 217 27 12.4% 19 7.8%
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
In Engineered Materials, at our Nanjing, China facility, our expansions of (1) the compounding plant is in construction was completed and we are accelerating completion to meet demand began production activities during the three months ended December 31, 2025 and (2) the new liquid crystal polymer ("LCP") plant is in construction and remains on schedule under a delayed timeline. for completion in the second half of 2026.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
In the accompanying consolidated financial statements, see Note 10 - Current Other Liabilities for current asset retirement obligations, Note 11 - Debt for a description of the guarantees under our Senior Notes and Revolving Credit Agreement, Facility, Note 12 - Benefit Obligations for a description of the pension and other postretirement funding obligations, Note 13 - Environmental for a description of environmental obligations, Note 15 - Income Taxes for a description of uncertain tax positions, Note 16 - Leases for lease obligations and Note 19 - Commitments and Contingencies for a discussion of commitments and contingencies related to legal and regulatory proceedings.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
As of December 31, 2024, 2025, we have $1.75 billion available for borrowing under our senior U.S. unsecured revolving credit facility, $171 million available for borrowing under our separate China Revolving Credit Facilities (defined below) and up to $1.0 billion under the November 2024 U.S.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
We calculated $2.5 billion of all estimate future interest payments on debt and other obligations calculated using the rate interest rates in effect on December 31, 2024 and $493 million of all future pension and other postretirement funding obligations. 2025 to be $3.5 billion.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
In August 2023, (3)On March 14, 2025, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): in aggregate principal amounts of €750 million and $1.8 billion (the "March 2025 Offering").
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
The net proceeds from the 2023 Offering Term Loan Credit Facility, were used (i) to fund the March 2025 Tender Offer and Offers, (ii) for the repayment of other outstanding indebtedness. indebtedness, including a portion of the March 2022 U.S.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
In August 2023, (4)On December 17, 2025, Celanese U.S. completed a public offering of senior unsecured notes registered under the Securities Act as follows (collectively, the "2023 Offering"): in an aggregate principal amount of $1.4 billion (the "December 2025 Offering").
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
(ii) its merger or consolidation with, or transfer of all or substantially all of its assets to, another person; or (iii) its ceasing to be a majority-owned subsidiary of the Issuer in connection with any sale of its capital stock or other transaction.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
For further information regarding the acquisition and related financing transactions, see Debt and Other Obligations in this Liquidity and Capital Resources and See Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesMD&A
In October 2023, we announced the intended closure of our PA66 and certain High-Performance Nylon ("HPN") polymerization units at our facility in Uentrop, Germany to optimize production costs across our global network.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new